geha semaglutide New study finds cardiovascular benefit of Semaglutide helps reduce risk of

Macitentan: Check LFT and Hemoglobin

Most academic obesity medicine programs teach that GLP-1 monotherapy should be maximized first, and only if weight loss plateaus despite adequate dosing should additional agents be consideredalways under close specialist supervision

10.1016/j.phrs.2017.09.002 102 LiY.ChenM.WangJ.GuoX.XiaoL.LiuP.et al (2019)

Both produce stronger sustained clinical results than Sermorelin in our patient population

However, we always recommend refrigerating it as soon as it arrives to maximize its long-term shelf life

However, semaglutide (2.4 mg weekly) is said to have broken the sound barrier (19), inducing 9.6% weight loss in patients with obesity and T2D (20) and 14.9% weight loss in patients with obesity alone (21) over 68 weeks of treatment